•  
  •  
  •  
  •  

2025-10-06 05:04:57

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Nykaa Quarterly Revenue Update - Q2 FY2026
  • Utkarsh Small Finance Bank Ltd - Q2FY26 Business Update
  • HCL Infosystems Ltd receives final arbitration award in arbitration filed against UIDAI
  • Bank of Baroda - Q2 FY2026 Business Update
  • JTL Industries report highest ever H1 FY26 Volumes at 1,82,210 MT, records 3.5% YoY growth

Keywords Selected:  DET

Stock Report

  • CarTrade Tech's Platforms, CarWale & BikeWale Traffic Soars 74% to Record High This Navratri
  • Jyothy Labs Ltd launches Liquid Deterget 'Dr. Wool®'
  • ZyVet® launches affordable Furosemide tablets to support long-term heart care trusted diuretic for dogs and cats now available in a generic form
  • G E Shipping contracts to sell its 2005 built Suezmax Crude Tanker 'Jag Lok'
  • GST Reduction Boosts Auto Demand
  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • CarTrade Tech Ltd consolidated Q1FY26 PAT at Rs. 42.87 crores
  • Subex Launches FraudZap™ - A Lightweight Fraud Detection Platform - Debuts with Handset Fraud Use Case
  • J.B. Chemicals & Pharmaceuticals Ltd receives USFDA approval for ANDA Amitriptyline Hydrochloride Tablets
  • Lupin launches Prucalopride tablets in the United States
  • Lupin receives approval from U.S. FDA for Prucalopride Tablets
  • CarTrade Labs to Drive Innovation and Shape the Future of Technology
  • J B Chemicals and Pharmaceuticals Ltd receives ANDA approval for Amitriptyline Hydrochloride Tablets from USFDA
  • HCLFoundation signs MoUs with the Government of Tamil Nadu to boost entrepreneurship and vocational education
  • Airtel launches Fraud Detection Solution, a First in the World
  • CarTrade Tech Ltd Q4 FY25 consolidated PAT drops QoQ to Rs. 41.82 crores
  • Airtel announces new features in its continued fight against SPAM
  • Concord Biotech Limited receives final approval from USFDA for Teriflunomide Tablets
  • Hindustan Zinc deploys first-of-its-kind AI solution for enhancing Workplace Safety
  • Zydus receives final approval from USFDA for Apalutamide Tablets, 60 mg
  • CarWale, BikeWale, and OLX India Each Cross 150 Million Yearly Unique Users for CarTrade Tech
  • GOCL Corporation Limited Update on Detonators and other Blasting Initiation Devices operations at Kukatpally
  • CarTrade Tech Celebrates Strong Festive Season Performance in October 2024
  • Indoco Remedies receives final ANDA approval from the USFDA for Cetirizine Hydrochloride Tablets USP, 10 mg OTC

Mutual Funds

  • Groww Mutual Fund Introduces Groww Gold ETF: A Smarter, Simpler Way to Invest in Gold
  • Shriram AMC launches Shriram NIFTY 1D Rate Liquid ETF - Growth
  • Axis Mutual Fund launches 'Axis US Treasury Dynamic Bond ETF Fund of Fund'
  • UTI Mutual Fund launches 'UTI Gold ETF Fund of Fund'
  • Edelweiss Mutual Fund to launch third tranche of 'BHARAT Bond ETF' on 3rd December 2021

Latest Post

  • Nykaa Quarterly Revenue Update - Q2 FY2026
  • Utkarsh Small Finance Bank Ltd - Q2FY26 Business Update
  • HCL Infosystems Ltd receives final arbitration award in arbitration filed against UIDAI
  • Bank of Baroda - Q2 FY2026 Business Update
  • JTL Industries report highest ever H1 FY26 Volumes at 1,82,210 MT, records 3.5% YoY growth


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024